Polycystic ovary syndrome, recently discussed in some contexts as polyendocrine metabolic ovarian syndrome (PMOS), affects how hormones work and influences the ovaries. It is one of the most common hormonal conditions in women of reproductive age, with estimates suggesting it impacts around 10-13% of women worldwide, though many remain undiagnosed.
Many women first notice changes in their periods, such as irregular or absent cycles, along with skin issues like acne, excess hair growth on the face or body (hirsutism), or thinning hair on the scalp. Weight changes, difficulty managing weight, and challenges with conceiving can also appear. These symptoms vary widely; some women experience several, while others have milder or fewer signs. Symptoms can start in the teenage years but are sometimes dismissed as part of puberty, stress, or normal variation.
Diagnosis typically involves assessing at least two of three key features after ruling out other causes: irregular ovulation or periods, signs of higher androgen levels (clinically or through blood tests), and the appearance of polycystic ovaries on ultrasound. Ultrasound alone does not confirm or exclude the condition.
A diagnosis does not mean constant medical intervention. Many women manage well with lifestyle approaches focused on healthy eating, activity, and weight management where relevant. Medicines may help regulate periods, reduce androgen effects, support fertility, or address metabolic concerns. Symptoms can evolve across life stages, including pregnancy and later years.
PCOS connects to higher risks of insulin resistance, type 2 diabetes, and certain cardiovascular markers, though these vary individually. Fertility issues often relate to irregular ovulation rather than egg quality, and many women conceive naturally or with support like ovulation induction.
In pregnancy, there is a higher chance of gestational diabetes and some hypertensive disorders, influenced by factors like metabolic profile. Postnatal follow-up, particularly after gestational diabetes, can be inconsistent.
Women often describe long journeys to diagnosis, seeing multiple professionals and receiving fragmented explanations. This reflects broader patterns in women’s health where symptoms spanning hormones, metabolism, skin, and mental wellbeing are addressed in separate services.
Internal links for further reading:
Explore related pages on menstrual health, fertility and reproductive care, and metabolic health in women.
If these pages are showing a 404, please check back later, the website is still under construction.
References
- National Institute for Health and Care Excellence. Polycystic ovary syndrome: diagnosis and management. Available at: https://www.nice.org.uk
- NHS England. Women’s Health Strategy for England. Available at: https://www.england.nhs.uk
- MBRRACE-UK. Perinatal surveillance reports. Available at: https://www.npeu.ox.ac.uk/mbrrace-uk
- National Institute for Health and Care Research. PCOS evidence collections. Available at: https://evidence.nihr.ac.uk
- Healthcare Safety Investigation Branch / HSSIB. Investigation reports. Available at: https://www.hssib.org.uk
- International evidence-based guideline for the assessment and management of PCOS (2023). Monash University / partner societies.
- WHO fact sheet on polycystic ovary syndrome.
Mandatory disclaimer This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed.
This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy. This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.
© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.